Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM1FN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,333
Award facts
- Contract value 100% obligated
- $25,332.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,333 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on December 24, 2025. This is a firm fixed price, non-set-aside contract with a completion deadline of January 16, 2026, and the product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ocrevus is a specialty pharmaceutical used in the treatment of multiple sclerosis, reflecting the Defense Logistics Agency's ongoing procurement of specialized therapeutic medications to support military and veteran healthcare systems.
This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's receipt of competitively awarded contracts across multiple therapeutic domains demonstrates the company's established capability to meet federal procurement requirements for critical medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM1FN?
SPE2DR26FM1FN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 24, 2025.
How much is contract SPE2DR26FM1FN worth?
The government has obligated $25,333 on SPE2DR26FM1FN.
Is contract SPE2DR26FM1FN an order under another contract?
Yes. SPE2DR26FM1FN is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1FN competed?
The extent of competition for SPE2DR26FM1FN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award